Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,571
total citations
- FWCI
- 26.31
- Percentile
- 100%
- References
- 101
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- Pegaptanib
- Aptamer
- Macular degeneration
- Vascular endothelial growth factor
- Choroidal neovascularization
- Medicine
- Pharmacology
- Neovascularization
No related works found for this paper.